MV Capital Management’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.26K Hold
179
– – ﹤0.01% 726
2026
Q2
$2.87K Sell
179
-3
-2% -$50 ﹤0.01% 734
2026
Q1
$3.37K Buy
182
+154
+550% +$2.7K ﹤0.01% 680
2025
Q4
$437 Buy
+28
New +$400 ﹤0.01% 935

Other funds holding TAK

MV Capital Management's TAK Position: Q3 2026 in Review

MV Capital Management held its Takeda Pharmaceutical (TAK) position steady in Q3 2026 at 179 shares worth $3.26K. The position accounts for ﹤0.01% of the portfolio, ranked #726.

MV Capital Management first reported a position in TAK in Q4 2025 and has held it in 4 quarters since. The position peaked at $3.37K in Q1 2026. 400 funds tracked by Wall St. Rank hold TAK as of Q3 2026.

  • MV Capital Management held 179 shares of Takeda Pharmaceutical worth $3.26K as of Q3 2026.
  • MV Capital Management left its Takeda Pharmaceutical share count unchanged in Q3 2026.
  • Takeda Pharmaceutical made up ﹤0.01% of MV Capital Management's portfolio in Q3 2026, its #726 holding.
  • MV Capital Management first reported a position in Takeda Pharmaceutical in Q4 2025 and has held it in 4 quarters since.
  • MV Capital Management's Takeda Pharmaceutical position peaked at $3.37K in Q1 2026.
  • 400 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.

Based on MV Capital Management's 13F filing for Q3 2026, filed 29 Oct 2026.